Literature DB >> 27605947

PCI techniques to aid implantation of CRT-D in a senior patient with persistent left superior vena cava.

Qiang Wu1, Sha Yu1, Ya-Ping An1, Bao-Lin Chen1.   

Abstract

Entities:  

Keywords:  Cardiac resynchronization therapy; Heart failure; Implantation; Left superior vena cava

Year:  2016        PMID: 27605947      PMCID: PMC4996841          DOI: 10.11909/j.issn.1671-5411.2016.07.001

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN: 1671-5411            Impact factor:   3.327


× No keyword cloud information.
Persistent left superior vena cava (PLSVC) is a rare congenital anomaly of the vena cava, affecting about 0.5% of the general population, which poses a particular obstacle during transvenous electronic device implantation. Here, we report a successful cardiac resynchronization therapy-defibrillator device (CRT-D) implantation strategy in which techniques and devices for percutaneous coronary intervention were used via a PLSVC. A 73-year-old man was admitted to our hospital due to 13 years progressive exertional dyspnea with NewYork Heart Association (NYHA) class III. Transthoracic echocardiography (TTE) revealed abnormal left ventricular parameters with a left ventricular end-diastolic dimension of 65.9 mm and an ejection fraction (EF) of 21%. Mechanical dyssynchrony between the left ventricular septum and the free wall area was also observed via the TTE. The electrocardiography showed sinus rhythm, and complete left bundle branch block with a QRS duration of 160 ms (Figure 1A). The 24-h Holter monitoring electrocardiogram detected a frequent ventricular tachycardia and premature ventricular contractions. A diagnostic coronary angiography indicated three branch lesions in this patient, with a chronic total occlusion lesion in the right coronary artery.
Figure 1.

Baseline ECG (A) and ECG after CRT-D implantation (B).

CRT-D: cardiac resynchronization therapy-defibrillator device.

As a result, the patient was diagnosed with ischemic cardiomyopathy on the basis of the clinical features, the diagnostic coronary angiography, the progressive exertional dyspnea and transthoracic echocardiography. CRT-D implantation with Class I recommendation was explicit considering the presence of overt ventricular dyssynchrony, complete left bundle branch block (LBBB), NYHA class III and frequent ventricular arrhythmia. The patient approved the procedure with a written informed consent. The left subclavian vein puncture was uncomplicated. After the insertion of the guide wire, the locus of the guide wire on the left podoid implied the presence of PLSVC. Antegrade venography was performed and confirmed that PLSVC was drained into the right atrium via a giant coronary sinus, without any vein connecting to the right superior vena cava (RSVC), (Figure 2A). We failed to find any identifiable coronary sinus tributaries in retrograde venography via the right subclavian vein because it was impossible to occlude the enlarged coronary sinus temporarily (Figure 2B).
Figure 2.

Chest radiograph and angiogram.

(A): Venography shows persistent left superior vena cava with right superior vena cava; (B): retrograde coronary venogram, angiographic balloon failed to occlude the lumen of the vein; (C): selective coronary sinus tributaries venography with a JR catheter; and (D): positions of right atrial, right ventricular and coronary sinus leads in anteroposterior projection.

Though microcatheter angiography confirmed the guide wires were ultimately placed into two postero-lateral veins through the RSVC, the left ventricular lead (QUICK-FLEXTMµ, 1258T, St. Jude Medical, USA) could not be positioned in the coronary veins due to small vascular diameter. Selective coronary sinus tributaries venography was then successfully performed through the PLSVC by using a 5 F Judkins-type angiographic catheter (JR 4.0) (Figure 2C). Three guide wires were eventually placed into three lateral veins respectively. A guiding sheath (CPS PL-STR, St. Jude Medical, USA) was then used to replace the angiographic catheter. Finally, the left ventricular lead was successfully positioned in a lateral vein under the support of two other wires. Subsequently, a double-coil defibrillator active-fixation lead (DURATATM, 7120, St. Jude Medical, USA) was positioned at the right ventricular apex and an active-fixation lead (TENDRILTMST, 1888T, St. Jude Medical, USA) was placed into the right atrial appendage via the RSVC. The right heart leads were secured and reached the left subfascial prepectoral pocket across the subepidermis. After detecting acute parameters (threshold: left ventricle 0.8 V, right ventricle 0.7 V, right atrium 1.0 V, at 0.48 ms; wave potential: right ventricle 18 mV, right atrium 4.0 mV; impedance: left ventricle 1040 Ω, right ventricle 760 Ω, right atrium 560 Ω), all leads were eventually connected to a CRT-D device (V-350, St. Jude Medical, USA) (Figure 2D). Biventricular pacing narrowed the QRS duration after CRT-D implantation in this senior patient (Figure 1B).

Baseline ECG (A) and ECG after CRT-D implantation (B).

CRT-D: cardiac resynchronization therapy-defibrillator device. PLSVC is observed in 0.3%−0.5% of the general population as established by autopsy.[1] It results from a degradation failure of the left common cardinal vein, and is usually asymptomatic. This congenital anomaly has rarely been reported as a contingent finding during cardiac device implantation for the treatment of sick sinus node syndrome, atrio-ventricular block, non-standing ventricular tachycardia or heart failure.[2],[3] Diagnosis of a PLSVC in a senior patient (73-year-old) was surprising and really rare, especially in patients who needed a CRT-D implantation. The possibility of PLSVC should always be kept in mind when the guide wire declined on the left side of the thorax, as it was an incidental discovery during a cardiac device implantation. For the convenience of cannulation and the effectiveness of defibrillation, it is a better decision to implant the CRT-D through a left pectoral approach. Taking into account the difficulties in positioning the right ventricular lead via PLSVC, we attempted to place the three leads of CRT-D via right subclavian vein in this case. However, the left ventricular lead has failed to implant in any coronary sinus tributary through right subclavian vein due to the giant coronary sinus, the degraded image of retrograde coronary sinus venography, and the small tributaries in which the leads could not be manipulated.

Chest radiograph and angiogram.

(A): Venography shows persistent left superior vena cava with right superior vena cava; (B): retrograde coronary venogram, angiographic balloon failed to occlude the lumen of the vein; (C): selective coronary sinus tributaries venography with a JR catheter; and (D): positions of right atrial, right ventricular and coronary sinus leads in anteroposterior projection. In the present case, selective coronary sinus tributaries venography was successfully performed through the left subclavian vein and PLSVC with a JR coronary arteriography catheter. We then replaced the coronary arteriography catheter with the guiding sheath. Under the guidance of clear images of selective coronary sinus tributaries venography and the support of buddy wires, the left ventricular lead was successfully positioned in a lateral branch through PLSVC. The majority of PLSVC patients also have RSVC. The device implantation via the RSVC is therefore feasible and safe. The implantation of the device in patients with isolated PLSVC has proven more difficult due to the technically challenge in lead placement as well as in specific heart diseases, although there have been some reports about successful defibrillator or pacemaker lead implantations through PLSVC.[3]–[5] Thus, a left-side transvenous implantation or open chest surgery is mandatory due to the special anatomic abnormalities in some patients.[6] The successful CRT-D implantation in the present case indicates that it is feasible and safe to position the left ventricular lead via PLSVC, in which the techniques and instruments for percutaneous coronary intervention are helpful.
  6 in total

1.  Cardiac resynchronization therapy in patients with absent right but persistent left superior vena cava.

Authors:  A Kortner; A Keyser; C Schmid
Journal:  Thorac Cardiovasc Surg       Date:  2009-05-20       Impact factor: 1.827

2.  Implantable cardioverter defibrillator lead implantation in patients with a persistent left superior vena cava--feasibility, chances, and limitations: representative cases in adults.

Authors:  M Guenther; S Kolschmann; T P Rauwolf; M Christoph; V Sandfort; R H Strasser; C Wunderlich
Journal:  Europace       Date:  2012-09-19       Impact factor: 5.214

3.  Implantation of a cardiac resynchronization therapy-defibrillator device in a patient with persistent left superior vena cava.

Authors:  İlyas Atar; Emir Karaçağlar; Emre Özçalık; Bülent Özin; Haldun Müderrisoğlu
Journal:  Turk Kardiyol Dern Ars       Date:  2015-06

4.  Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience.

Authors:  M Biffi; G Boriani; L Frabetti; G Bronzetti; A Branzi
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

5.  Complications of permanent cardiac pacing in patients with persistent left superior vena cava.

Authors:  Anna Polewczyk; Andrzej Kutarski; Elżbieta Czekajska-Chehab; Piotr Adamczyk; Krzysztof Boczar; Maciej Polewczyk; Marianna Janion
Journal:  Cardiol J       Date:  2014-02-14       Impact factor: 2.737

6.  Implantation of transvenous permanent pacemaker in a patient with persistent left superior vena cava and absent right superior vena cava.

Authors:  Mohammad Javad Alemzadeh-Ansari; Akbar Shafiee; Ahmad Yaminisharif
Journal:  Int Cardiovasc Res J       Date:  2013-12-01
  6 in total
  1 in total

1.  Successful implantation of left ventricular lead for a cardiac resynchronization therapy defibrillator through a persistent left superior vena cava using the anchor balloon technique.

Authors:  Masatoshi Narikawa; Masayoshi Kiyokuni; Yuka Taguchi; Junya Hosoda; Tomoaki Ishigami; Toshiyuki Ishikawa; Kouichi Tamura; Kazuo Kimura
Journal:  J Cardiol Cases       Date:  2021-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.